Drug Trial Radar · NCT02407782
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults
Last checked: Nov 20, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,092
Actual
Start
Jan 19, 2016
Primary completion
Dec 16, 2021
Study completion Jan 18, 2022
Sponsor
- Lead sponsor
- University Hospital, BordeauxAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 3, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Scabies remains a frequent condition that affects adults and children. The aim of this study is to compare the efficacy and safety of two drug treatments against scabies in children and their close contacts. One group will apply topical permethrin 5% and the other group will receive oral ivermectin. Both groups will be treated twice, once at inclusion and the second time 10 days later. Both treatment regimens have been used widely and are safe to use.
Conditions
- Scabies
Interventions
IvermectinDrug
oral ivermectin, 200μg/kg given at baseline and at day 10.
PermethrinDrug
topical permethrin 5% cream applied at baseline and at day 10.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of skin lesions and healing at day 28Time frame: Day 28
Locations
29 sites in 2 countries. Site status is shown where the registry gives one.
APHP- Bobigny - Avicenne
Bobigny, France
CHU de Bordeaux - Saint André
Bordeaux, France
CHU de Brest
Brest, France
CHD Vendée
La Roche-sur-Yon, France
CH Le Havre
Le Havre, France
CHRU de Lille
Lille, France
AP-HM
Marseille, France
APHP Hôpital Cochin
Paris, France
CH de Périgueux
Périgueux, France
CHU de Reims
Reims, France
CHU de Rouen
Rouen, France
CHU de Saint-Etienne
Saint-Etienne, France
CHU de Bordeaux Hôpital Pellegrin
Bordeaux, Aquitaine, France
CHU de Lyon
Bron, Auvergne-Rhône-Alpes, France
CHG de Chalon sur Saône
Chalon-sur-Saône, Bourgogne-Franche-Comté, France
CHU de Dijon
Dijon, Bourgogne-Franche-Comté, France
CHU de Rennes
Rennes, Brittany Region, France
CHRU de Tours
Tours, Centre-Val de Loire, France
CH d'Argenteuil
Argenteuil, Île-de-France Region, France
CHU de Créteil - Hôpital Henry Mondor
Créteil, Île-de-France Region, France
AP-HP - Hôpital Robert Debré
Paris, Île-de-France Region, France
CHU de Montpellier
Montpellier, Languedoc-Roussillon, France
CHU de la Réunion
Saint-Pierre, Martinique, France
CHU d'Angers
Angers, Pays de la Loire Region, France
CH du Mans
Le Mans, Pays de la Loire Region, France
CHU de Nantes
Nantes, Pays de la Loire Region, France
CHI de Fréjus
Fréjus, Provence-Alpes-Côte d'Azur Region, France
CHU de Nice
Nice, Provence-Alpes-Côte d'Azur Region, France
CHU de Pointe à Pitre
Pointe-à-Pitre, Guadeloupe
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.